Back to results
US 12,502,403 B2Granted
Tafoxiparin for the treatment of preeclampsia
AssigneeDilafor AB
InventorsLena Degling-Wikingsson, Gunvor Ekman-Ordeberg, Stefan Hansson
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the use of the heparin derivative tafoxiparin in the treatment of preeclampsia (PE). The treatment may be monotherapy or combination therapy, where tafoxiparin is used in combination with an agent (drug) used as standard of care therapy in preeclampsia (PE).
Claims20
A method for the treatment of preeclampsia (PE) comprising administering a therapeutically effective amount of tafoxiparin to a subject in need of such treatment.
Dependencies are inferred from the claim text.